Tuesday, 12 August 2008

Roche's XCELLigence System Designed To Reduce Animal Testing In Pharmaceutical Development

�BOTOX� is an important medicine that over the last 15 years of clinical use has helped millions of patients with serious medical conditions oecumenical. Pharmaceutical manufacturers using Clostridium botulinum toxin (BOTOX�) in drugs ar required by the Food and Drug Administration (FDA) in the United States and by other worldwide health regulative agencies to protect patients and consumers by assuring product safety and efficaciousness through beast testing and other methods.

In a recent study (Biochemica 4/2008, in photographic print), James O'Connell et.al. from ACEA Biosciences in San Diego have secondhand the label-free, real